OTC Pharmaceuticals - Spain | Statista Market Forecast

The revenue generated in the OTC Pharmaceuticals market in Spain is projected to amount to US$3.05bn in 2024.
It is anticipated that the market will experience an annual growth rate of 4.63% (CAGR 2024-2029).
Within this market, the largest market is Cold & Cough Remedies, which is expected to reach a market volume of US$768.40m in 2024.
In comparison to other countries, the United States generates the highest revenue with US$41.24bn in 2024.
When considering the population, it can be observed that per person revenues amount to US$64.29 in 2024.
Furthermore, it is estimated that 12.74% of the total revenue in the OTC Pharmaceuticals market will be generated through online sales by 2024.
The demand for over-the-counter pharmaceuticals in Spain is driven by a growing aging population and a preference for self-medication.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Spain has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.Customer preferences play a crucial role in the growth of the OTC Pharmaceuticals market in Spain. Consumers are increasingly seeking convenience and accessibility when it comes to healthcare products. OTC medications offer a convenient alternative to prescription drugs, as they can be purchased without a doctor's prescription. This allows consumers to address common health issues quickly and easily, without the need for a doctor's visit. Additionally, the affordability of OTC medications compared to prescription drugs makes them an attractive option for cost-conscious consumers.Trends in the market also contribute to the growth of the OTC Pharmaceuticals market in Spain. One notable trend is the increasing focus on self-care and preventive healthcare. Consumers are becoming more proactive in managing their health and are turning to OTC medications to address minor ailments and prevent more serious health issues. This trend is driven by a growing awareness of the importance of maintaining good health and the availability of a wide range of OTC products that cater to specific health needs.Local special circumstances in Spain also impact the growth of the OTC Pharmaceuticals market. Spain has a well-developed healthcare system that provides universal coverage to its citizens. However, the system is also burdened with long waiting times and limited access to healthcare professionals, especially in rural areas. As a result, consumers often turn to OTC medications as a first line of defense for common health issues. Furthermore, the high level of trust in pharmacists in Spain plays a significant role in driving the demand for OTC medications. Pharmacists are seen as reliable and knowledgeable healthcare professionals who can provide advice and recommendations on OTC products.Underlying macroeconomic factors have also contributed to the growth of the OTC Pharmaceuticals market in Spain. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income among consumers. This has resulted in higher healthcare spending, including the purchase of OTC medications. Additionally, the aging population in Spain has created a growing market for OTC products that cater to the specific health needs of older adults.In conclusion, the OTC Pharmaceuticals market in Spain has been growing due to customer preferences for convenience and affordability, trends towards self-care and preventive healthcare, local special circumstances such as limited access to healthcare professionals, and underlying macroeconomic factors such as economic growth and an aging population.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.